ibuprofen has been researched along with Androgen-Independent Prostatic Cancer in 1 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Festuccia, C | 1 |
| Gravina, GL | 1 |
| Mancini, A | 1 |
| Muzi, P | 1 |
| Cesare, ED | 1 |
| Kirk, R | 1 |
| Smith, M | 1 |
| Hughes, S | 1 |
| Gibson, R | 1 |
| Lian, LY | 1 |
| Ricevuto, E | 1 |
| Carnell, AJ | 1 |
1 other study available for ibuprofen and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferat | 2014 |